Evidence map›Paper›PMID 32039019›Full record

ArticleFrontiers in oncology2019

Consolidative Chemoradiotherapy After Induced Chemotherapy Is an Optimal Regimen for Locally Advanced Pancreatic Cancer.

Lili Wu, Yuhong Zhou, Yue Fan, Shengxiang Rao, Yuan Ji, Jing Sun, Tingting Li, Shisuo Du, Xi Guo, Zhaochong Zeng and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak?Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2020
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Lili WuDepartment of Radiotherapy, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Yuhong ZhouDepartment of Medical Oncology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Yue FanDepartment of Traditional Chinese Medicine, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Shengxiang RaoDepartment of Radiology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Yuan JiDepartment of Pathology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Jing SunDepartment of Radiotherapy, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Tingting LiDepartment of Radiotherapy, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Shisuo DuDepartment of Radiotherapy, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Xi GuoDepartment of Medical Oncology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Zhaochong ZengDepartment of Radiotherapy, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Wenhui LouDepartment of General Surgery, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Zhongshan Hospital · CNSun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemoradiotherapychemotherapylocally advanced pancreatic cancermultidiciplinary treatmentneoadjuvant treatment

Identifiers

PMID32039019
PMCPMC6985361
OpenAlexW3002168540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.